KALEIDO BIOSCIENCES, INC. Assets, Fair Value Disclosure
KALEIDO BIOSCIENCES, INC. had Assets, Fair Value Disclosure of $25.42 million as of 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2022-04-01
- 2021-12-31: Assets, Fair Value Disclosure $25.42M.
- 2021-09-30: Assets, Fair Value Disclosure $25.41M.
- 2021-06-30: Assets, Fair Value Disclosure $25.41M.
- 2021-03-31: Assets, Fair Value Disclosure $25.41M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $25.42M 10-K · filed 2022-04-01 |
| 2021-09-30 | $25.41M 10-Q · filed 2021-11-01 |
| 2021-06-30 | $25.41M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $25.41M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $45.41M 10-K · filed 2022-04-01 |
| 2020-09-30 | $45.41M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $45.40M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $25.38M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $25.30M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $80.72M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $98.28M 10-Q · filed 2019-08-01 |
| 2018-12-31 | $74.14M 10-K · filed 2020-03-02 |